Skip to main content
SpringerLink
Log in

Nonprofit foundations for open-source biomedical technology development

  • Commentary
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

For academic discoveries eschewed by traditional venture capital business models, there is now an alternative path.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1

References

  1. Huggett, B. Nat. Biotechnol. 30, 395–400 (2012).

    Article  CAS  Google Scholar 

  2. Frangioni, J.V. Nat. Biotechnol. 26, 503–507 (2008).

    Article  CAS  Google Scholar 

  3. Frangioni, J.V. J. Clin. Oncol. 26, 4012–4021 (2008).

    Article  Google Scholar 

  4. Mieog, J.S. et al. Ann. Surg. Oncol. 18, 2483–2491 (2011).

    Article  Google Scholar 

  5. Troyan, S.L. et al. Ann. Surg. Oncol. 16, 2943–2952 (2009).

    Article  Google Scholar 

  6. Choi, H.S. et al. Angew. Chem. Int. Edn. Engl. 50, 6258–6263 (2011).

    Article  CAS  Google Scholar 

  7. Gioux, S., Choi, H.S. & Frangioni, J.V. Mol. Imaging 9, 237–255 (2010).

    Article  CAS  Google Scholar 

  8. Hutteman, M. et al. Ann. Surg. Oncol. 18, 1006–1014 (2011).

    Article  Google Scholar 

  9. Lee, B.T. et al. Plast. Reconstr. Surg. 126, 1472–1481 (2010).

    Article  CAS  Google Scholar 

  10. van der Vorst, J.R. et al. Int. J. Gynecol. Cancer 21, 1472–1478 (2011).

    Article  Google Scholar 

Download references

Acknowledgements

I thank P. Ariniello, C. Colecchi, M. Herman, J. Hoppin, L. Keys, S. Levin, A. Lo, S. Madigan, L. Moffitt, F. Monti, J. Murgia, B. Preston, M. Rosenberg, J. Rosenbloom and M. Tweedle for many helpful discussions and L. Gendall for editing.

Author information

Authors and Affiliations

  1. John V. Frangioni is at Harvard Medical School, Center for Molecular Imaging, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.,

    John V Frangioni

Authors
  1. John V Frangioni
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to John V Frangioni.

Ethics declarations

Competing interests

FLARE technology is owned by Beth Israel Deaconess Medical Center, a teaching hospital of Harvard Medical School, Cambridge, Massachusetts, USA. It has been licensed to the FLARE Foundation, a nonprofit organization focused on promoting the dissemination of medical imaging technology for research and clinical use. J. Frangioni is the founder and chairman of the FLARE Foundation. The Beth Israel Deaconess Medical Center will receive royalties for sale of FLARE Technology. J. Frangioni has elected to surrender post-market royalties to which he would otherwise be entitled as inventor and has elected to donate pre-market proceeds to the FLARE Foundation. J. Frangioni has started three for-profit companies, Curadel, Curadel Medical Devices and Curadel In Vivo Diagnostics, which may someday be non-exclusive sublicensees of FLARE technology.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Frangioni, J. Nonprofit foundations for open-source biomedical technology development. Nat Biotechnol 30, 928–932 (2012). https://doi.org/10.1038/nbt.2392

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt.2392

  • Springer Nature America, Inc.

This article is cited by

Search

Navigation